TY - JOUR AU - Inoue, K. AU - Ogawa, H. AU - Sonoda, Y. AU - Kimura, T. AU - Sakabe, H. AU - Oka, Y. AU - Miyake, S. AU - Tamaki, H. AU - Oji, Y. AU - Yamagami, T. PY - 1997 DA - 1997// TI - Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia JO - Blood VL - 89 ID - Inoue1997 ER - TY - JOUR AU - Menssen, H. D. AU - Renkl, H. J. AU - Rodeck, U. AU - Maurer, J. AU - Notter, M. AU - Schwartz, S. AU - Reinhardt, R. AU - Thiel, E. PY - 1995 DA - 1995// TI - Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias JO - Leukemia VL - 9 ID - Menssen1995 ER - TY - JOUR AU - Miwa, H. AU - Beran, M. AU - Saunders, G. F. PY - 1992 DA - 1992// TI - Expression of the Wilms' tumor gene (WT1) in human leukemias JO - Leukemia VL - 6 ID - Miwa1992 ER - TY - JOUR AU - Nakatsuka, S. AU - Oji, Y. AU - Horiuchi, T. AU - Kanda, T. AU - Kitagawa, M. AU - Takeuchi, T. AU - Kawano, K. AU - Kuwae, Y. AU - Yamauchi, A. AU - Okumura, M. PY - 2006 DA - 2006// TI - Immunohistochemical detection of WT1 protein in a variety of cancer cells JO - Mod Pathol VL - 19 ID - Nakatsuka2006 ER - TY - JOUR AU - Sugiyama, H. PY - 2002 DA - 2002// TI - Cancer immunotherapy targeting WT1 protein JO - Int J Hematol VL - 76 UR - https://doi.org/10.1007/BF02982574 DO - 10.1007/BF02982574 ID - Sugiyama2002 ER - TY - JOUR AU - Oka, Y. AU - Tsuboi, A. AU - Oji, Y. AU - Kawase, I. AU - Sugiyama, H. PY - 2008 DA - 2008// TI - WT1 peptide vaccine for the treatment of cancer JO - Curr Opin Immunol VL - 20 UR - https://doi.org/10.1016/j.coi.2008.04.009 DO - 10.1016/j.coi.2008.04.009 ID - Oka2008 ER - TY - JOUR AU - Rezvani, K. AU - Yong, A. S. AU - Mielke, S. AU - Savani, B. N. AU - Musse, L. AU - SUperata, J. AU - Jafapour, B. AU - Boss, C. AU - Barrett, A. J. PY - 2008 DA - 2008// TI - Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies JO - Blood VL - 111 UR - https://doi.org/10.1182/blood-2007-08-108241 DO - 10.1182/blood-2007-08-108241 ID - Rezvani2008 ER - TY - JOUR AU - Keilholz, U. AU - Letsch, A. AU - Busse, A. AU - Asemissen, A. M. AU - Bauer, S. AU - Blau, I. W. AU - Hofmann, W. K. AU - Uharek, L. AU - Thiel, E. AU - Scheibenbogen, C. PY - 2009 DA - 2009// TI - A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS JO - Blood VL - 113 UR - https://doi.org/10.1182/blood-2009-02-202598 DO - 10.1182/blood-2009-02-202598 ID - Keilholz2009 ER - TY - JOUR AU - Gajewski, T. F. AU - Meng, Y. AU - Harlin, H. PY - 2006 DA - 2006// TI - Immune suppression in the tumor microenvironment JO - J Immunother VL - 29 UR - https://doi.org/10.1097/01.cji.0000199193.29048.56 DO - 10.1097/01.cji.0000199193.29048.56 ID - Gajewski2006 ER - TY - JOUR AU - Seliger, B. PY - 2005 DA - 2005// TI - Strategies of tumor immune evasion JO - BioDrugs VL - 19 UR - https://doi.org/10.2165/00063030-200519060-00002 DO - 10.2165/00063030-200519060-00002 ID - Seliger2005 ER - TY - JOUR AU - Kim, R. AU - Emi, M. AU - Tanabe, K. PY - 2007 DA - 2007// TI - Cancer immunoediting from immune surveillance to immune escape JO - Immunology VL - 121 UR - https://doi.org/10.1111/j.1365-2567.2007.02587.x DO - 10.1111/j.1365-2567.2007.02587.x ID - Kim2007 ER - TY - JOUR AU - Slingluff, C. L. AU - Colella, T. A. AU - Thompson, L. AU - Graham, D. D. AU - Skipper, J. C. AU - Caldwell, J. AU - Brinckerhoff, L. AU - Kittlesen, D. J. AU - Deacon, D. H. AU - Oei, C. PY - 2000 DA - 2000// TI - Melanomas with concordant loss of multiple melanocytic differentiation proteins: immune escape that may be overcome by targeting unique or undefined antigens JO - Cancer Immunol Immunother VL - 48 UR - https://doi.org/10.1007/s002620050015 DO - 10.1007/s002620050015 ID - Slingluff2000 ER - TY - JOUR AU - Singh, R. AU - Paterson, Y. PY - 2007 DA - 2007// TI - Immunoediting sculpts tumor epitopes during immunotherapy JO - Cancer Res VL - 67 UR - https://doi.org/10.1158/0008-5472.CAN-06-3960 DO - 10.1158/0008-5472.CAN-06-3960 ID - Singh2007 ER - TY - JOUR AU - Seifert, U. AU - Liermann, H. AU - Racanelli, V. AU - Halenius, A. AU - Wiese, M. AU - Wedemeyer, H. AU - Ruppert, T. AU - Rispeter, K. AU - Henklein, P. AU - Sijts, A. PY - 2004 DA - 2004// TI - Hepatitis C virus mutation affects proteasomal epitope processing JO - J Clin Invest VL - 114 UR - https://doi.org/10.1172/JCI200420985 DO - 10.1172/JCI200420985 ID - Seifert2004 ER - TY - JOUR AU - Theobald, M. AU - Ruppert, T. AU - Kuckelkorn, U. AU - Hernandez, J. AU - Haussler, A. AU - Ferreira, E. A. AU - Liewer, U. AU - Biggs, J. AU - Levine, A. J. AU - Huber, C. PY - 1998 DA - 1998// TI - The sequence alteration associated with a mutational hotspot in p53 protects cells from lysis by cytotoxic T lymphocytes specific for a flanking peptide epitope JO - J Exp Med VL - 188 UR - https://doi.org/10.1084/jem.188.6.1017 DO - 10.1084/jem.188.6.1017 ID - Theobald1998 ER - TY - JOUR AU - Marincola, F. M. AU - Jaffee, E. M. AU - Hicklin, D. J. AU - Ferrone, S. PY - 2000 DA - 2000// TI - Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance JO - Adv Immunol VL - 74 UR - https://doi.org/10.1016/S0065-2776(08)60911-6 DO - 10.1016/S0065-2776(08)60911-6 ID - Marincola2000 ER - TY - JOUR AU - Algarra, I. AU - Cabrera, T. AU - Garrido, F. PY - 2000 DA - 2000// TI - The HLA crossroad in tumor immunology JO - Hum Immunol VL - 61 UR - https://doi.org/10.1016/S0198-8859(99)00156-1 DO - 10.1016/S0198-8859(99)00156-1 ID - Algarra2000 ER - TY - JOUR AU - Watson, N. F. AU - Ramage, J. M. AU - Madjd, Z. AU - Spendlove, I. AU - Ellis, I. O. AU - Scholefield, J. H. AU - Durrant, L. G. PY - 2006 DA - 2006// TI - Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis JO - Int J Cancer VL - 118 UR - https://doi.org/10.1002/ijc.21303 DO - 10.1002/ijc.21303 ID - Watson2006 ER - TY - JOUR AU - Seliger, B. AU - Atkins, D. AU - Bock, M. AU - Ritz, U. AU - Ferrone, S. AU - Huber, C. AU - Storkel, S. PY - 2003 DA - 2003// TI - Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter-associated with antigen-processing down-regulation JO - Clin Cancer Res VL - 9 ID - Seliger2003 ER - TY - JOUR AU - Seliger, B. AU - Maeurer, M. J. AU - Ferrone, S. PY - 2000 DA - 2000// TI - Antigen-processing machinery breakdown and tumor growth JO - Immunol Today VL - 21 UR - https://doi.org/10.1016/S0167-5699(00)01692-3 DO - 10.1016/S0167-5699(00)01692-3 ID - Seliger2000 ER - TY - JOUR AU - Garcia-Lora, A. AU - Martinez, M. AU - Algarra, I. AU - Gaforio, J. J. AU - Garrido, F. PY - 2003 DA - 2003// TI - MHC class I-deficient metastatic tumor variants immunoselected by T lymphocytes originate from the coordinated downregulation of APM components JO - Int J Cancer VL - 106 UR - https://doi.org/10.1002/ijc.11241 DO - 10.1002/ijc.11241 ID - Garcia-Lora2003 ER - TY - JOUR AU - Siehl, J. M. AU - Thiel, E. AU - Heufelder, K. AU - Snarski, E. AU - Schwartz, S. AU - Mailander, V. AU - Keilholz, U. PY - 2003 DA - 2003// TI - Possible regulation of Wilms' tumour gene 1 (WT1) expression by the paired box genes PAX2 and PAX8 and by the haematopoietic transcription factor GATA-1 in human acute myeloid leukaemias JO - Br J Haematol VL - 123 UR - https://doi.org/10.1046/j.1365-2141.2003.04622.x DO - 10.1046/j.1365-2141.2003.04622.x ID - Siehl2003 ER - TY - JOUR AU - King-Underwood, L. AU - Pritchard-Jones, K. PY - 1998 DA - 1998// TI - Wilms' tumor (WT1) gene mutations occur mainly in acute myeloid leukemia and may confer drug resistance JO - Blood VL - 91 ID - King-Underwood1998 ER - TY - JOUR AU - Summers, K. AU - Stevens, J. AU - Kakkas, I. AU - Smith, M. AU - Smith, L. L. AU - Macdougall, F. AU - Cavenagh, J. AU - Bonnet, D. AU - Young, B. D. AU - Lister, T. A. AU - Fitzgibbon, J. PY - 2007 DA - 2007// TI - Wilms' tumour 1 mutations are associated with FLT3-ITD and failure of standard induction chemotherapy in patients with normal karyotype AML JO - Leukemia VL - 21 UR - https://doi.org/10.1038/sj.leu.2404514 DO - 10.1038/sj.leu.2404514 ID - Summers2007 ER - TY - JOUR AU - Chang, C. C. AU - Ferrone, S. PY - 2007 DA - 2007// TI - Immune selective pressure and HLA class I antigen defects in malignant lesions JO - Cancer Immunol Immunother VL - 56 UR - https://doi.org/10.1007/s00262-006-0183-1 DO - 10.1007/s00262-006-0183-1 ID - Chang2007 ER -